GHR and cancer: In humans, extensive studies in Ecuadorians with Laron Syndrome (LS), caused by germline inactivating mutations in the GH receptor (GHR), demonstrate improved insulin sensitivity, resistance to diabetes and cancer, enhanced memory function, and decreased pro-aging signaling [4].